SEC Tracker
Get the app

GT Biopharma GTBP

GT Biopharma files S-1 for stock offering

Securities offering

Form
S-1
Filed
Importance
Notable
  1. Registering 13,502,835 shares of common stock
  2. Includes shares from September 2026 private placement
  3. Shares include conversion of preferred stock and warrants

Written from the S-1 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when GT Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Biovie BIVI public float $8M, Dec 31, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  4. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
  5. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025